48 related articles for article (PubMed ID: 24432894)
1. High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era.
Blaker YN; Eide MB; Liestøl K; Lauritzsen GF; Kolstad A; Fosså A; Smeland EB; Holte H
Leuk Lymphoma; 2014 Oct; 55(10):2319-27. PubMed ID: 24432894
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant.
Pasvolsky O; Bassett RL; Ghanem S; Cuglievan B; Tewari P; Hosing C; Srour S; Ramdial J; Mahadeo KM; Khazal S; Petropoulos D; Popat U; Qazilbash M; Kebriaei P; Champlin R; Shpall EJ; Nieto Y
BMC Cancer; 2023 Dec; 23(1):1258. PubMed ID: 38124057
[TBL] [Abstract][Full Text] [Related]
3. Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin Lymphoma.
Nieto Y; Banerjee P; Kaur I; Kim KH; Fang D; Thall PF; Griffin L; Barnett M; Basar R; Hosing C; Ramdial J; Srour S; Daher M; Marin D; Jiang X; Chen K; Champlin R; Shpall EJ; Rezvani K
Transplant Cell Ther; 2024 Feb; 30(2):203.e1-203.e9. PubMed ID: 38042257
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy and autologous hematopoietic stem cell transplantation for progressive systemic sclerosis: a retrospective study of outcome and prognostic factors.
Pyka V; Vangala DB; Mika T; Kreuter A; Susok L; Baraliakos X; Treiber H; Schroers R; Nilius-Eliliwi V
J Cancer Res Clin Oncol; 2024 Jun; 150(6):301. PubMed ID: 38850365
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era.
Vardhana SA; Sauter CS; Matasar MJ; Zelenetz AD; Galasso N; Woo KM; Zhang Z; Moskowitz CH
Br J Haematol; 2017 Feb; 176(4):591-599. PubMed ID: 27982423
[TBL] [Abstract][Full Text] [Related]
6. EFFICACY OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN ADULT BURKITT/BURKITT-LIKE LYMPHOMA: A SYSTEMATIC REVIEW.
Joshi U; Subedi R; Nepal G; Gyawali S; Agrawal V; Poudyal BS; Bhatt VR; D'Angelo CR
Exp Oncol; 2022 Nov; 44(3):190-197. PubMed ID: 36325697
[TBL] [Abstract][Full Text] [Related]
7. HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL).
Krishnan A; Palmer JM; Zaia JA; Tsai NC; Alvarnas J; Forman SJ
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1302-8. PubMed ID: 20353830
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study.
Baech J; Husby S; Trab T; Kragholm K; Brown P; Gørløv JS; Jørgensen JM; Gudbrandsdottir S; Severinsen MT; Grønbaek K; Larsen TS; Wästerlid T; Eloranta S; Smeland KB; Jakobsen LH; El-Galaly TC
Br J Haematol; 2024 Mar; 204(3):967-975. PubMed ID: 38155503
[TBL] [Abstract][Full Text] [Related]
9. Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma.
Farouk Sait S; Bernot MR; Klein E; Abramson DH; Francis JH; Gilheeney S; Karajannis MA; Spitzer B; Wolden S; Dunkel IJ; Kernan NA
Pediatr Blood Cancer; 2023 Jan; 70(1):e29921. PubMed ID: 35934994
[TBL] [Abstract][Full Text] [Related]
10. Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study.
Wu M; Wang F; Zhao S; Li Y; Huang W; Nie B; Liu H; Liu X; Li W; Yu H; Yi K; Dong F; Dong Y; Yuan C; Ran X; Xiao X; Liu W; Zhu J
Ann Hematol; 2023 Nov; 102(11):3185-3193. PubMed ID: 37700194
[TBL] [Abstract][Full Text] [Related]
11. Autologous Stem Cell Transplantation in Adult Hodgkin Lymphoma at a Tertiary Care Center in India: Analysis of Outcomes and Prognostic Factors.
Kumar S; Sharma A; Bakhshi S; Pushpam D; Gogia A; Sahoo RK; Pramanik R; Kumar A; Pathak N; Thulkar S; Sharma MC; Gupta R; Mallick S; Raina V
Indian J Hematol Blood Transfus; 2024 Apr; 40(2):181-189. PubMed ID: 38708163
[TBL] [Abstract][Full Text] [Related]
12. Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: an analysis from the European Society for Blood and Marrow Transplantation.
Heilig CE; Badoglio M; Labopin M; Fröhling S; Secondino S; Heinz J; Nicolas-Virelizier E; Blaise D; Korenbaum C; Santoro A; Verbeek M; Krüger W; Siena S; Passweg JR; Di Nicola M; Rifón J; Dreger P; Koehl U; Chabannon C; Pedrazzoli P
ESMO Open; 2020 Oct; 5(5):e000860. PubMed ID: 33097652
[TBL] [Abstract][Full Text] [Related]
13. Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support.
von Drygalski A; Tran TB; Messer K; Pu M; Corringham S; Nelson C; Ball ED
Int J Breast Cancer; 2011; 2011():523276. PubMed ID: 22295228
[TBL] [Abstract][Full Text] [Related]
14. New strategies in chronic lymphocytic leukemia: shifting treatment paradigms.
Awan FT; Byrd JC
Clin Cancer Res; 2014 Dec; 20(23):5869-74. PubMed ID: 25294898
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness analysis of different salvage therapy intensities used for diffuse large B-cell lymphoma in Northern or Southern Alberta: an instrumental variable analysis.
Oh DH; Ghosh S; Chua N; Kostaras X; Tilley D; Chu M; Owen CJ; Stewart DA
Leuk Lymphoma; 2015 Jun; 56(6):1756-62. PubMed ID: 25284495
[TBL] [Abstract][Full Text] [Related]
16. Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma.
Fiskvik I; Beiske K; Delabie J; Yri O; Spetalen S; Karjalainen-Lindsberg ML; Leppä S; Liestøl K; Smeland EB; Holte H
Leuk Lymphoma; 2015 Jun; 56(6):1742-9. PubMed ID: 25284491
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib for the treatment of non-Hodgkin's lymphoma.
Bose P; Batalo MS; Holkova B; Grant S
Expert Opin Pharmacother; 2014 Nov; 15(16):2443-59. PubMed ID: 25263936
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States.
Nastoupil LJ; Sinha R; Byrtek M; Ziemiecki R; Taylor M; Friedberg JW; Koff JL; Link BK; Cerhan JR; Dawson KL; Flowers CR
Leuk Lymphoma; 2015 May; 56(5):1295-302. PubMed ID: 25263322
[TBL] [Abstract][Full Text] [Related]
19. Lymphopenia predicts preclinical relapse in the routine follow-up of patients with diffuse large B-cell lymphoma.
Wei X; Wei Y; Huang F; Jing H; Xie M; Hao X; Feng R
Leuk Lymphoma; 2015 May; 56(5):1261-5. PubMed ID: 25175043
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS).
Wagner-Johnston ND; Link BK; Byrtek M; Dawson KL; Hainsworth J; Flowers CR; Friedberg JW; Bartlett NL
Blood; 2015 Aug; 126(7):851-7. PubMed ID: 26105149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
